Add to ORKGBackground The benefits of reducing blood pressure on the risks of major cardiovascular disease are well established, but uncertainty remains about the comparative effects of different blood-pressure-lowering regimens. We aimed to estimate effects of strategies based on different drug classes (angiotensin-converting-enzyme [ACE] inhibitors, calcium antagonists, angiotensin-receptor blockers [ARBs], and diuretics or P blockers) or those targeting different blood pressure goals, on the risks of major cardiovascular events and death.status: publishe
Background Angiotensin-converting enzyme inhibitors (ACEis) and angiotensin II receptor blockers (A...
Background The benefits of reducing blood pressure are well established, but there remains uncertain...
Objectives To evaluate the blood pressure-dependent and independent effects of angiotensin-convertin...
BACKGROUND: The benefits of reducing blood pressure on the risks of major cardiovascular disease are...
Background The benefits of reducing blood pressure on the risks of major cardiovascular disease are ...
BACKGROUND: This programme of overviews of randomised trials was established to investigate the effe...
Background Cardiovascular disease is a leading cause of mortality and morbidity worldwide. Blood p...
OBJECTIVE: To conduct prospectively planned overviews (meta-analyses) of the ongoing randomized tria...
OBJECTIVE: To conduct prospectively planned overviews (meta-analyses) of the ongoing randomized tria...
In a quantitative overview of published trials, we investigated whether pharmacologic properties of ...
BACKGROUND: Whether antihypertensive drugs offer cardiovascular protection beyond blood pressure low...
OBJECTIVE: To systematically evaluate the efficacy of five commonly used blood pressure-lowering dru...
Background The effects of pharmacological blood pressure lowering at normal or high-normal blood pre...
The benefits of blood pressure lowering treatment for prevention of cardiovascular disease are well ...
Background: The benefits of reducing blood pressure are well established, but there remains uncertai...
Background Angiotensin-converting enzyme inhibitors (ACEis) and angiotensin II receptor blockers (A...
Background The benefits of reducing blood pressure are well established, but there remains uncertain...
Objectives To evaluate the blood pressure-dependent and independent effects of angiotensin-convertin...
BACKGROUND: The benefits of reducing blood pressure on the risks of major cardiovascular disease are...
Background The benefits of reducing blood pressure on the risks of major cardiovascular disease are ...
BACKGROUND: This programme of overviews of randomised trials was established to investigate the effe...
Background Cardiovascular disease is a leading cause of mortality and morbidity worldwide. Blood p...
OBJECTIVE: To conduct prospectively planned overviews (meta-analyses) of the ongoing randomized tria...
OBJECTIVE: To conduct prospectively planned overviews (meta-analyses) of the ongoing randomized tria...
In a quantitative overview of published trials, we investigated whether pharmacologic properties of ...
BACKGROUND: Whether antihypertensive drugs offer cardiovascular protection beyond blood pressure low...
OBJECTIVE: To systematically evaluate the efficacy of five commonly used blood pressure-lowering dru...
Background The effects of pharmacological blood pressure lowering at normal or high-normal blood pre...
The benefits of blood pressure lowering treatment for prevention of cardiovascular disease are well ...
Background: The benefits of reducing blood pressure are well established, but there remains uncertai...
Background Angiotensin-converting enzyme inhibitors (ACEis) and angiotensin II receptor blockers (A...
Background The benefits of reducing blood pressure are well established, but there remains uncertain...
Objectives To evaluate the blood pressure-dependent and independent effects of angiotensin-convertin...